In particular, TNF alpha levels have been shown to be elevated in CSF in patients with AQP4 and MOG IgG autoimmunity, but not in patients with MS, and therefore the effect of TNF inhibition is likely different in these CNS inflammatory disorders (113). This evidence concerns the gene AQP4 and myeloid sarcoma.